Suma Krishnan - Net Worth and Insider Trading
Suma Krishnan Net Worth
The estimated net worth of Suma Krishnan is at least $514 Million dollars as of 2024-04-26. Suma Krishnan is the President, R&D, 10% Owner of Krystal Biotech Inc and owns about 3,303,144 shares of Krystal Biotech Inc (KRYS) stock worth over $514 Million. Suma Krishnan is also the SVP--Product Development of Precigen Inc and owns about 84,000 shares of Precigen Inc (PGEN) stock worth over $117,600. Details can be seen in Suma Krishnan's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Suma Krishnan has not made any transactions after 2024-03-11 and currently still holds the listed stock(s).
Transaction Summary of Suma Krishnan
Suma Krishnan Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Suma Krishnan owns 2 companies in total, including Krystal Biotech Inc (KRYS) , and Precigen Inc (PGEN) .
Click here to see the complete history of Suma Krishnan’s form 4 insider trades.
Insider Ownership Summary of Suma Krishnan
Ticker | Comapny | Transaction Date | Type of Owner |
---|---|---|---|
KRYS | Krystal Biotech Inc | 2024-03-11 | director & 10 percent owner & Chief Operating Officer |
PGEN | Precigen Inc | 2015-12-04 | SVP--Product Development |
Suma Krishnan Latest Holdings Summary
Suma Krishnan currently owns a total of 2 stocks. Among these stocks, Suma Krishnan owns 3,303,144 shares of Krystal Biotech Inc (KRYS) as of March 11, 2024, with a value of $514 Million and a weighting of 99.98%. Suma Krishnan also owns 84,000 shares of Precigen Inc (PGEN) as of December 4, 2015, with a value of $117,600 and a weighting of 0.02%.
Latest Holdings of Suma Krishnan
Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
---|---|---|---|---|---|
KRYS | Krystal Biotech Inc | 2024-03-11 | 3,303,144 | 155.68 | 514,233,458 |
PGEN | Precigen Inc | 2015-12-04 | 84,000 | 1.40 | 117,600 |
Holding Weightings of Suma Krishnan
Suma Krishnan Form 4 Trading Tracker
According to the SEC Form 4 filings, Suma Krishnan has made a total of 17 transactions in Krystal Biotech Inc (KRYS) over the past 5 years, including 0 buys and 17 sells. The most-recent trade in Krystal Biotech Inc is the sale of 50,000 shares on March 11, 2024, which brought Suma Krishnan around $9 Million.
According to the SEC Form 4 filings, Suma Krishnan has made a total of 0 transactions in Precigen Inc (PGEN) over the past 5 years. The most-recent trade in Precigen Inc is the sale of 20,900 shares on December 4, 2015, which brought Suma Krishnan around $745,294.
Insider Trading History of Suma Krishnan
- 1
Suma Krishnan Trading Performance
GuruFocus tracks the stock performance after each of Suma Krishnan's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Suma Krishnan is 13.7%. GuruFocus also compares Suma Krishnan's trading performance to market benchmark return within the same time period. The performance of stocks bought by Suma Krishnan within 3 months outperforms 2 times out of 3 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Suma Krishnan's insider trading performs compared to the benchmark.
Performance of Suma Krishnan
Average Return
98.3%
Outperforming Transactions
100%
1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
---|---|---|---|---|---|---|
Return(%) | 6.86 | 13.7 | 48.52 | 98.3 | 91.42 | 55.97 |
Relative Return to S&P 500(%) | 6.43 | 11.19 | 45.92 | 89.14 | 81.79 | 41.84 |
Suma Krishnan Ownership Network
Ownership Network List of Suma Krishnan
Ownership Network Relation of Suma Krishnan
Suma Krishnan Owned Company Details
What does Krystal Biotech Inc do?
Who are the key executives at Krystal Biotech Inc?
Suma Krishnan is the director & 10 percent owner & Chief Operating Officer of Krystal Biotech Inc. Other key executives at Krystal Biotech Inc include director & 10 percent owner & President and CEO Krish S Krishnan , Chief Accounting Officer Kathryn Romano , and Chief Commercial Officer Andrew C. Orth .
Krystal Biotech Inc (KRYS) Insider Trades Summary
Over the past 18 months, Suma Krishnan made 11 insider transaction in Krystal Biotech Inc (KRYS) with a net sale of 350,000. Other recent insider transactions involving Krystal Biotech Inc (KRYS) include a net sale of 350,000 shares made by Krish S Krishnan , a net sale of 76,515 shares made by Kathryn Romano , and a net sale of 125,000 shares made by Daniel Janney .
In summary, during the past 3 months, insiders sold 120,587 shares of Krystal Biotech Inc (KRYS) in total and bought 0 shares, with a net sale of 120,587 shares. During the past 18 months, 954,015 shares of Krystal Biotech Inc (KRYS) were sold and 0 shares were bought by its insiders, resulting in a net sale of 954,015 shares.
Krystal Biotech Inc (KRYS)'s detailed insider trading history can be found in Insider Trading Tracker table.
Krystal Biotech Inc Insider Transactions
Suma Krishnan Mailing Address
Above is the net worth, insider trading, and ownership report for Suma Krishnan. You might contact Suma Krishnan via mailing address: 2100 Wharton Street, Suite 701, Pittsburgh Pa 15203.